N
Patient 1
DEVICE IS A COMBINATION PRODUCT.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SYNERGY | BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM | BOSTON SCIENTIFIC CORPORATION | NIQ | 10610 | 10610 | 0023634067 | R | N |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2020-03-30 | 0 | 1. R |
Patient 1
DEVICE IS A COMBINATION PRODUCT.
Patient 1
IT WAS REPORTED THAT STENT DISLODGMENT OCCURRED. THE 90% STENOSED TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS AND HEAVILY CALCIFIED CIRCUMFLEX ARTERY. A 2.50 X 16 SYNERGY DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, THE STENT WAS DISLODGED FROM THE DELIVERY SYSTEM. THE STENT WAS LOCATED IN THE VESSEL AND WAS SUBSEQUENTLY CRUSHED AND SECURED BY A NEW STENT. THE PROCEDURE WAS COMPLETED AND NO PATIENT COMPLICATIONS NOR INJURIES WERE REPORTED. THE PATIENT WAS DISCHARGED.